Vor Biopharma Inc. — Director's Dealing 2021

Aug 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vor Biopharma Inc. (VOR)
CIK: 0001817229
Period of Report: 2021-08-17

Reporting Person: Chakraborty Tirtha (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-17	Common Stock	M	17446	$1.36	Acquired	20980	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-17	Employee Stock Option (right to buy)	$1.36	M	17446	Disposed	2029-09-24	Common Stock (17446)	Direct

Footnotes

F1: 1/4th of the shares underlying the option vested on September 23, 2020, with the remainder vesting in equal monthly installments over 3 years, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.